Elixophyllin Sr

   
Google
 
Web NewDrugInformation.com

Elixophyllin Sr


Drug - Elixophyllin Sr
The trade name of the product as shown on the labeling.

Dosage - CAPSULE, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Theophylline
Multiple ingredients are in alphabetical order.

Strength - 250MG
The potency of the active ingredient(s), Theophylline. May repeat for multiple part products.

Applicant - FOREST LABS
The firm name holding legal responsibility for Elixophyllin Sr. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 086826
The FDA assigned number to Elixophyllin Sr. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Elixophyllin Sr. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 29, 1985
The date Elixophyllin Sr was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Elixophyllin Sr. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Elixophyllin Sr is in. Format is RX, OTC, DISCN.

Applicant Full Name - Forest Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Elixophyllin Sr.

Elixophyllin Sr